Posted by Michael Wonder on 08 Aug 2018
Trump administration opens up more drugs covered by Medicare to price negotiations
7 August 2018 - The Centers for Medicare & Medicaid Services will allow Medicare Advantage plans to negotiate prices of medicines covered under Medicare Part B.
Pharmaceutical companies will soon have to negotiate prices for more drugs.
The Centers for Medicare & Medicaid Services will allow Medicare Advantage plans to negotiate prices of medicines covered under Medicare Part B, which covers drugs typically administered by a physician. These tend to be more expensive treatments like rheumatoid arthritis drugs and some cancer drugs.
